Medicare Enrolled
Dr. Usha Nayak, MD,ABSM
Pulmonary Disease · Gainesville, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nayak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nayak?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nayak
Dr. Usha Nayak is a pulmonary disease specialist in Gainesville, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nayak performed 3,231 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Nayak received a total of $3,735 from 26 pharmaceutical and/or device companies across 101 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nayak is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 7% volume in GA
$3,735 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,231
Medicare services
Top 7% in GA for pulmonary disease
Not available
Unique patients (not deduplicated)
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
800 | $92 | $387 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
637 | $62 | $230 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
525 | $59 | $274 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
168 | $11 | $44 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
167 | $13 | $52 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
113 | $12 | $48 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
107 | $94 | $354 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
76 | $101 | $395 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
72 | $134 | $539 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
63 | $121 | $503 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
59 | $73 | $339 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
58 | $86 | $356 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
56 | $6 | $25 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
56 | $93 | $368 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
54 | $66 | $303 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
50 | $131 | $541 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
38 | $29 | $30 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
37 | $282 | $1,419 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
27 | $209 | $805 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
25 | $100 | $556 |
| New patient office visit, complex (60-74 min) | 17 | $162 | $664 |
| Chest fluid aspiration with imaging guidance This procedure involves removing fluid from the chest cavity using imaging technology to guide the needle placement. |
14 | $85 | $919 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
12 | $87 | $336 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$3,735
Total received (2018-2024)
Avg $534/year across 7 years
Top 43% in GA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
101
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$535
2023
$355
2022
$391
2021
$226
2020
$331
2019
$1,135
2018
$761
Payments by company (2024)
Regeneron Healthcare Solutions, Inc.
$135
GlaxoSmithKline, LLC.
$134
Actelion Pharmaceuticals US, Inc.
$72
Grifols USA, LLC
$44
AstraZeneca Pharmaceuticals LP
$25
Fisher & Paykel Healthcare Inc
$25
JAZZ PHARMACEUTICALS INC.
$24
Takeda Pharmaceuticals U.S.A., Inc.
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Philips North America LLC
$15
Sandoz Inc.
$15
Top 3 companies account for 63.9% of 2024 payments
All-time payments by company (2018-2024) ›
Olympus Corporation of the Americas
$969
Veran Medical Technologies, Inc.
$736
GlaxoSmithKline, LLC.
$415
United Therapeutics Corporation
$248
Regeneron Healthcare Solutions, Inc.
$152
Philips Electronics North America Corporation
$151
Boehringer Ingelheim Pharmaceuticals, Inc.
$151
Inspire Medical Systems, Inc.
$125
AstraZeneca Pharmaceuticals LP
$125
Grifols USA, LLC
$120
Actelion Pharmaceuticals US, Inc.
$109
Mylan Specialty L.P.
$59
Electromed, Inc.
$55
UCB, Inc.
$44
Teva Pharmaceuticals USA, Inc.
$44
Mallinckrodt Hospital Products Inc.
$32
Axsome Therapeutics, Inc.
$26
CSL Behring
$25
Fisher & Paykel Healthcare Inc
$25
JAZZ PHARMACEUTICALS INC.
$24
Takeda Pharmaceuticals U.S.A., Inc.
$23
Resmed Corp
$18
Baxter Healthcare
$16
Philips North America LLC
$15
Sandoz Inc.
$15
Advanced Respiratory, Inc
$13
Top 3 companies account for 56.8% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIR 11 · AIRSUPRA · ANORO ELLIPTA · AREXVY · AirDuo Digihaler · BREZTRI · DUPIXENT · FASENRA · FISHER & PAYKEL HEALTHCARE · GLASSIA · Hillrom - Life 2000 Ventilation System · Inspire Upper Airway Stimulation System · Life 2000 Ventilation System · NUCALA · Neupro · OFEV · OPSUMIT · Olympus EBUS Bronchoscopes · Prolastin-C · Prolastin-C Liquid · SMARTVEST · STIOLTO RESPIMAT · Spin · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TREPROSTINIL · TYVASO · XYWAV · Xembify · YUPELRI · Yupelri · Zemaira
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
14
County median income
$77,430
Nearest hospital to ZIP centroid (approximate)
NORTHEAST GEORGIA MEDICAL CENTER, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nayak is a clinical cardiology specialist, with above-average Medicare volume (top 7% in GA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nayak experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Nayak performed 800 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Nayak receive payments from pharmaceutical companies?
Yes. Dr. Nayak received a total of $3,735 from 26 companies across 101 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nayak's costs compare to other pulmonary diseases in Gainesville?
Dr. Nayak's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nayak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Gainesville
Browse pulmonary diseases in Gainesville ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in GA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in GA
Which GA pulmonary diseases receive the most from drug and device companies.
By company
Olympus Corporation of the Americas Payments to Doctors
See all physicians who received payments from Olympus Corporation of the Americas.
By company
Veran Medical Technologies, Inc. Payments to Doctors
See all physicians who received payments from Veran Medical Technologies, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology